Literature DB >> 8474431

Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.

E Chu1, D M Koeller, P G Johnston, S Zinn, C J Allegra.   

Abstract

The effects of fluorouracil (5-FU) and interferon-gamma (IFN-gamma) on the regulation of thymidylate synthase (TS) gene expression were investigated in the human colon cancer H630 cell line. By Western immunoblot analysis, TS protein levels in H630 cells were increased 3-, 5.5-, 5-, and 2.5-fold after 8-, 16-, 24-, and 36-hr exposure to 1 microM 5-FU, respectively. When H630 cells were exposed to varying concentrations of 5-FU (0.3-10 microM) for 24 hr, increases in TS protein up to 5.5-fold were observed. A 24-hr exposure to 1 microM 5-FU resulted in a 4.5-fold increase in the level of TS protein, whereas in 5-FU/IFN-gamma-treated cells TS protein was increased by only 1.8-fold, compared with control cells. IFN-gamma treatment alone did not affect TS protein levels, relative to control. Northern blot analysis revealed no changes in TS mRNA levels when H630 cells were exposed either to 1 microM 5-FU for 8-36 hr, to varying concentrations of 5-FU (0.3-10 microM) for 24 hr, or to the combination of 5-FU and IFN-gamma. Pulse-labeling studies with [35S]methionine demonstrated a 3.5-fold increase in net synthesis of TS in cells treated with 1 microM 5-FU, whereas the level of newly synthesized TS increased only 1.5-fold in cells treated with 5-FU/IFN-gamma, compared with control cells. Pulse-chase studies revealed that the half-lives of TS protein in control and 5-FU-treated cells were equivalent. These findings demonstrate that the increase in TS protein after 5-FU exposure and the subsequent inhibitory effect of IFN-gamma on TS protein expression are both regulated at the post-transcriptional level.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8474431

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  37 in total

1.  Variants of human thymidylate synthase with loop 181-197 stabilized in the inactive conformation.

Authors:  Leslie L Lovelace; Saphronia R Johnson; Lydia M Gibson; Brittnaie J Bell; Sondra H Berger; Lukasz Lebioda
Journal:  Protein Sci       Date:  2009-08       Impact factor: 6.725

2.  Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex.

Authors:  E Chu; S M Copur; J Ju; T M Chen; S Khleif; D M Voeller; N Mizunuma; M Patel; G F Maley; F Maley; C J Allegra
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 3.  Pharmacologic resistance in colorectal cancer: a review.

Authors:  William A Hammond; Abhisek Swaika; Kabir Mody
Journal:  Ther Adv Med Oncol       Date:  2016-01       Impact factor: 8.168

4.  Characterization of a cis-acting regulatory element in the protein coding region of thymidylate synthase mRNA.

Authors:  X Lin; L A Parsels; D M Voeller; C J Allegra; G F Maley; F Maley; E Chu
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

5.  Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells.

Authors:  P J Ferguson; J M DeMoor; M D Vincent; J Koropatnick
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 6.  Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years.

Authors:  Mariusz Panczyk
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 7.  Pathological complete response after neoadjuvant therapy for rectal cancer and the role of adjuvant therapy.

Authors:  Valerie M Nelson; Al B Benson
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

8.  Characterization of a specific interaction between Escherichia coli thymidylate synthase and Escherichia coli thymidylate synthase mRNA.

Authors:  D M Voeller; L M Changchien; G F Maley; F Maley; T Takechi; R E Turner; W R Montfort; C J Allegra; E Chu
Journal:  Nucleic Acids Res       Date:  1995-03-11       Impact factor: 16.971

9.  Role of caspases in 5-FU and selenium-induced growth inhibition of colorectal cancer cells.

Authors:  Aye Aye Thant; Yanyuan Wu; Jane Lee; Dhruva Kumar Mishra; Heather Garcia; H Phillip Koeffler; Jaydutt V Vadgama
Journal:  Anticancer Res       Date:  2008 Nov-Dec       Impact factor: 2.480

Review 10.  Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil. Is it time to move forward?

Authors:  Shayna L Showalter; Timothy N Showalter; Agnes Witkiewicz; Robert Havens; Eugene P Kennedy; Tomas Hucl; Scott E Kern; Charles J Yeo; Jonathan R Brody
Journal:  Cancer Biol Ther       Date:  2008-04-21       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.